Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants

Wang, Fengze; Li, Li; Dou, Yang; Shi, Rui; Duan, Xiaomin; Liu, Hongchuan; Zhang, Jing; Liu, DanDan; Wu, Jing; He, Yang; Lan, Jun; Lu, Bai; Feng, Hui; Yan, Jinghua

doi:10.1080/22221751.2022.2032374

Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants

Journal Article · 01 February 2022 · Emerg. Microbes Infec.

DOI:https://doi.org/10.1080/22221751.2022.2032374· OSTI ID:1900790

Wang, Fengze; Li, Li; Dou, Yang; Shi, Rui; Duan, Xiaomin; Liu, Hongchuan; Zhang, Jing; Liu, DanDan; Wu, Jing; He, Yang; Lan, Jun; Lu, Bai; Feng, Hui; Yan, Jinghua

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; FOREIGN

OSTI ID:: 1900790

Journal Information:: Emerg. Microbes Infec., Vol. 11, Issue (1)

Country of Publication:: United States

Language:: ENGLISH

References (9)

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants Griffin, M. Pamela; Yuan, Yuan; Takas, Therese New England Journal of Medicine, Vol. 383, Issue 5 https://doi.org/10.1056/NEJMoa1913556	journal	July 2020
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics Mulangu, Sabue; Dodd, Lori E.; Davey, Richard T. New England Journal of Medicine, Vol. 381, Issue 24 https://doi.org/10.1056/NEJMoa1910993	journal	December 2019
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 Dougan, Michael; Nirula, Ajay; Azizad, Masoud New England Journal of Medicine, Vol. 385, Issue 15 https://doi.org/10.1056/NEJMoa2102685	journal	October 2021
Tackling COVID-19 with neutralizing monoclonal antibodies Corti, Davide; Purcell, Lisa A.; Snell, Gyorgy Cell, Vol. 184, Issue 12 https://doi.org/10.1016/j.cell.2021.05.005	journal	June 2021
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies Baum, Alina; Fulton, Benjamin O.; Wloga, Elzbieta Science https://doi.org/10.1126/science.abd0831	journal	June 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 Shi, Rui; Shan, Chao; Duan, Xiaomin Nature, Vol. 584, Issue 7819 https://doi.org/10.1038/s41586-020-2381-y	journal	May 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Barnes, Christopher O.; Jette, Claudia A.; Abernathy, Morgan E. Nature, Vol. 588, Issue 7839 https://doi.org/10.1038/s41586-020-2852-1	journal	October 2020
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants McCallum, Matthew; Walls, Alexandra C.; Sprouse, Kaitlin R. Science, Vol. 374, Issue 6575 https://doi.org/10.1126/science.abl8506	journal	December 2021
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 Starr, Tyler N.; Greaney, Allison J.; Dingens, Adam S. Cell Reports Medicine, Vol. 2, Issue 4 https://doi.org/10.1016/j.xcrm.2021.100255	journal	April 2021

Similar Records

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations

Journal Article · 2021 · Nature Immunology · OSTI ID:1837258

Dussupt, Vincent; Sankhala, Rajeshwer S.; Mendez-Rivera, Letzibeth; +43 more

Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants

Citation Formats

References (9)

Similar Records

Related Subjects